Copper ions stimulate the proliferation of hepatic stellate cells via oxygen stress in vitro

  • San-qing Xu (徐三清)
  • Hui-yun Zhu (朱慧云)
  • Jian-guo Lin (林剑国)
  • Tang-feng Su (苏堂枫)
  • Yan Liu (刘 艳)
  • Xiao-ping Luo (罗小平)
Article

Summary

This study examined the effect of copper ions on the proliferation of hepatic stellate cells (HSCs) and the role of oxidative stress in this process in order to gain insight into the mechanism of hepatic fibrosis in Wilson’s disease. LX-2 cells, a cell line of human HSCs, were cultured in vitro and treated with different agents including copper sulfate, N-acetyl cysteine (NAC) and buthionine sulfoximine (BSO) for different time. The proliferation of LX-2 cells was measured by non-radioactive cell proliferation assay. Real-time PCR and Western blotting were used to detect the mRNA and protein expression of platelet-derived growth factor receptor β subunit (PDGFβR), ELISA to determine the level of glutathione (GSH) and oxidized glutathione (GSSG), dichlorofluorescein assay to measure the level of reactive oxygen species (ROS), and lipid hydroperoxide assay to quantify the level of lipid peroxide (LPO). The results showed that copper sulfate over a certain concentration range could promote the proliferation of LX-2 cells in a time- and dose-dependent manner. The effect was most manifest when LX-2 cells were treated with copper sulfate at a concentration of 100 μmol/L for 24 h. Additionally, copper sulfate could dose-dependently increase the levels of ROS and LPO, and decrease the ratio of GSH/GSSG in LX-2 cells. The copper-induced increase in mRNA and protein expression of PDGFβR was significantly inhibited in LX-2 cells pre-treated with NAC, a precursor of GSH, and this phenomenon could be reversed by the intervention of BSO, an inhibitor of NAC. It was concluded that copper ions may directly stimulate the proliferation of HSCs via oxidative stress. Anti-oxidative stress therapies may help suppress the copper-induced activation and proliferation of HSCs.

Key words

copper ions hepatic stellate cells oxidative stress hepatic fibrosis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pfeiffer RF. Wilson’s disease. Handb Clin Neurol, 2011,100:681–709PubMedCrossRefGoogle Scholar
  2. 2.
    Ala A, Walker AP, Ashkan K, et al. Wilson’s disease. Lancet, 2007,369(9559):397–408PubMedCrossRefGoogle Scholar
  3. 3.
    Friedman SL. Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol Rev, 2008,88:125–172PubMedCrossRefGoogle Scholar
  4. 4.
    Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology, 2008,134(6):1655–1669PubMedCrossRefGoogle Scholar
  5. 5.
    Wan XH, Li YW, Luo XP. Curcumin attenuated the lipid peroxidation and apoptotic liver injury in copper-overloaded rats. Chin J Pediatr (Chinese), 2007,45(8): 604–608Google Scholar
  6. 6.
    Schmittgen TD, Zakrajsek BA, Mills AG, et al. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem, 2000,285(2):194–204PubMedCrossRefGoogle Scholar
  7. 7.
    Lin J, Chen A. Activation of peroxisome proliferator-activated receptor-γ by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells. Lab Invest, 2008,88(5):529–540PubMedCrossRefGoogle Scholar
  8. 8.
    Zheng S, Yumei F, Chen A. De novo synthesis of glutathione is a prerequisite for curcumin to inhibit hepatic stellate cell (HSC) activation. Free Radic Biol Med, 2007,43(3):444–453PubMedCrossRefGoogle Scholar
  9. 9.
    Sun YL, Zhao JM, Li WS, et al. Clinical pathological features of child Wilson’s disease and the mechanism of hepatic fibrosis. Med J Chin PLA (Chinese), 2005,30(4): 300–302Google Scholar
  10. 10.
    Xu L, Hui AY, Albanis E, et al. Human hepatic stellate cell lines, LX-1 and LX-2: New tools for analysis of hepatic fibrosis. Gut, 2005,54(1):142–151PubMedCrossRefGoogle Scholar
  11. 11.
    Tian Y, Yang X, Jiang YF, et al. 4 cases of fulminant Wilson’s disease: the clinical features and treatments. Chin J Hepatol (Chinese), 2010,18(9):717–718Google Scholar
  12. 12.
    Merle U, Schaefer M, Ferenci P, et al. Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort study. Gut, 2007,56(1):115–120PubMedCrossRefGoogle Scholar
  13. 13.
    Campbell JS, Hughes SD, Gillbertson DG, et al. Platelet derived growth factor C induces liver fibrosis, seatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA, 2005,102(9):3389–3393PubMedCrossRefGoogle Scholar
  14. 14.
    Guimarães EL, Franceschi MF, Grivicich I, et al. Relationship between oxidative stress levels and activation state on a hepatic stellate cell line. Liver Int, 2006,26(4): 477–485PubMedCrossRefGoogle Scholar
  15. 15.
    Galli A, Svegliati-Baroni G, Ceni E, et al. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. Hepatology, 2005,41(5):1074–1084PubMedCrossRefGoogle Scholar
  16. 16.
    Urtasun R, Nieto N. Hepatic stellate cells and oxidative stress. Rev Esp Enferm Dig, 2007,(4):223–230Google Scholar

Copyright information

© Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • San-qing Xu (徐三清)
    • 1
  • Hui-yun Zhu (朱慧云)
    • 1
  • Jian-guo Lin (林剑国)
    • 2
  • Tang-feng Su (苏堂枫)
    • 1
  • Yan Liu (刘 艳)
    • 1
  • Xiao-ping Luo (罗小平)
    • 1
  1. 1.Department of Pediatrics, Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina
  2. 2.Department of Internal Medicine, School of MedicineSaint Louis UniversitySt LouisUSA

Personalised recommendations